New drugs in thoracic oncology: needs and knowledge – an online ERS Lung Cancer Assembly survey

In the last decade, systemic therapy for advanced lung cancer has become diverse, complex and personalised. These new therapies (monoclonal antibodies, tyrosine kinase inhibitors (TKIs) and immunotherapy) have a far different toxicity profile compared to chemotherapy. Furthermore, clinical indicatio...

Descripción completa

Detalles Bibliográficos
Autores principales: Berghmans, Thierry, Evison, Matthew, Blum, Torsten Gerriet, Peled, Nir, Cadranel, Jacques
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Respiratory Society 2018
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6119830/
https://www.ncbi.nlm.nih.gov/pubmed/30186846
http://dx.doi.org/10.1183/23120541.00040-2018

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6119830/
https://www.ncbi.nlm.nih.gov/pubmed/30186846
http://dx.doi.org/10.1183/23120541.00040-2018

Ejemplares similares